Subject: Did Big Pharma Earn Billions by Adding the Hepatitis B Vaccine to the Immunization Schedule?

From	VAXOPEDIA <[email protected]>
Subject	Did Big Pharma Earn Billions by Adding the Hepatitis B Vaccine to the Immunization Schedule?
Date	September 24, 2024 12:20 PM

Links have been removed from this email. Learn more in the FAQ.

Post : Did Big Pharma Earn Billions by Adding the Hepatitis B Vaccine to the Immunization Schedule?
URL : [link removed]
Posted : September 24, 2024 at 6:19 am
Author : Vincent Iannelli, MD
Tags : Aaron Siri, Big Pharma, chronic hepatitis B, hepatitis B vaccine, Roy Vagelos
Categories : Vaccine Fact Check

The claim that Big Pharma profits greatly from the hepatitis B vaccine overlooks the reality that treating chronic hepatitis B is far more expensive. While the vaccine costs about $17 per dose, treatments for chronic infections can reach tens of thousands. Vaccination is thus a cost-effective way to prevent severe health outcomes.

Continue reading ( [link removed] )

--

Manage Subscriptions
[link removed]

Unsubscribe:
[link removed]

Screenshot of the email generated on import

Message Analysis

Sender: n/a
Political Party: n/a
Country: n/a
State/Locality: n/a
Office: n/a
Email Providers:
- Wordpress.com